Tesamorelin 6mg + Ipamorelin 3mg + CJC 1295 3mg (no DAC) – 6/3/3 MG Blend Lyophilized Vial

Tesamorelin Ipamorelin CJC 1295 No DAC is a research-focused combination of three peptides that researchers study for growth hormone signaling, pulsatility, and pituitary-axis pathways. Mode Peptides Triple Growth Hormone Secretagogue Blend provides a high-purity formulation for advanced laboratory and scientific research.

This 6/3/3 MG blend combines Tesamorelin, Ipamorelin, and CJC-1295 no DAC to target three distinct yet complementary mechanisms of endogenous GH release. By combining a GHRH analog, a long-acting GHRH analog, and a selective ghrelin-mimetic. Researchers can investigate a comprehensive, biomimetic GH pulse without the use of exogenous growth hormone.

What’s Inside The Blend:

Tesamorelin 6mg: A stabilized analog of human Growth Hormone-Releasing Hormone (GHRH). Originally developed to reduce visceral adiposity, Tesamorelin is studied for its potent stimulation of the pituitary to produce and release GH, its effects on IGF-1, lipolysis, cognitive function, and visceral fat metabolism. It provides a strong initial GHRH signal.

Ipamorelin 3mg: A highly selective Growth Hormone Secretagogue and ghrelin mimetic. Ipamorelin is the most selective GH secretagogue available. Stimulates a strong GH pulse while avoiding significant release of cortisol, prolactin, or acetylcholine. It is prized for clean GH release, improved sleep architecture research, and minimal side-effect profile in research models.

CJC-1295 3mg (no DAC – Mod GRF 1-29): A tetrasubstituted GHRH analog consisting of 29 amino acids. The “no DAC” version does NOT contain Drug Affinity Complex, meaning it has a shorter half-life and promotes a natural, pulsatile GH release pattern rather than a prolonged GH bleed. It amplifies the number of somatotroph cells releasing GH and extends the duration of the GHRH signal.

Together, Tesamorelin + CJC-1295 (no DAC) amplify the GHRH pathway, while Ipamorelin activates the complementary ghrelin receptor (GHS-R1a) pathway. This dual-pathway activation is studied for synergistic GH pulses far greater than either pathway alone.

Product Specifications of tesamorelin ipamorelin cjc 1295 (no dac):

• Formulation: 6mg Tesamorelin / 3mg Ipamorelin / 3mg CJC-1295 no DAC per vial
• Total Peptide: 12mg
• Form: Lyophilized Powder
• Purity: >99%
• Storage: Store at -20°C, protect from light/moisture
• Reconstitution: Soluble in bacteriostatic water

Research Applications: Endogenous GH and IGF-1 pulsatility, lean mass accretion vs. fat mass reduction, visceral adipose tissue metabolism, sleep quality and recovery models, connective tissue and injury repair, anti-aging and cellular rejuvenation pathways, and pituitary responsiveness. For Research Use Only.

Research Use Only

Tesamorelin, Ipamorelin, and CJC 1295 No DAC is intended exclusively for controlled laboratory and scientific research. Researchers may study this peptide combination in experimental models involving growth hormone signaling, pituitary-axis pathways, receptor activity, and related cellular mechanisms. For research use only, researchers should not use this material for human use, animal use, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. Qualified laboratory personnel should handle and evaluate the material according to established research protocols, institutional requirements, and applicable laboratory safety procedures.